Eyenuk’s Synthetic Intelligence-powered eye screening to assist Norway’s nationwide well being system handle ophthalmologist shortages and cut back preventable blindness from diabetes
Eyenuk, a worldwide chief in AI-powered eye screening, introduced that its EyeArt AI Eye Screening System has been chosen for deployment within the South-Jap Norway Regional Well being Authority (Helse Sør-Øst RHF) with goals to scale its use throughout Norway’s Nationwide Well being System within the coming years. This marks the primary time {that a} nationwide well being system anyplace has broadly adopted autonomous AI know-how for detection of eye illness.
The contracting and deployment have been facilitated by Human Bytes, a Nordic specialist within the secure and moral implementation and scaling of AI for healthcare and a distributor for the EyeArt system. The initiative will help Norway’s bold aim to make sure that greater than 95 p.c of individuals with diabetes obtain well timed retinal examinations, in contrast with simply 55 p.c at the moment.
The South-Jap Norway Regional Well being Authority is the biggest of Norway’s 4 regional well being methods, overlaying 3.1 million folks, over half of Norway’s inhabitants. Given its dimension and strategic location—together with Oslo, Norway’s capital—it performs a pivotal position in nationwide healthcare supply and innovation.
Additionally Learn: AiThority Interview with Dr. Petar Tsankov, CEO and Co-Founder at LatticeFlow AI
Diabetic retinopathy is the commonest complication of diabetes and the main reason for imaginative and prescient loss and blindness in working-age adults. In Norway, one in two folks with diabetes doesn’t obtain satisfactory follow-up care, largely on account of a scarcity of ophthalmologists and constrained well being sources. By leveraging the EyeArt system’s autonomous AI capabilities, the South-Jap Norway Regional Well being Authority goals to broaden capability, cut back bottlenecks, and supply well timed, equitable entry to diabetic eye screenings.
“[EyeArt] helps us to look at extra folks with diabetes,” mentioned Ulrich Spreng, Medical Director on the South-Jap Norway Regional Well being Authority. “With higher use of healthcare professionals’ time, we anticipate that the ready time for retinal examinations will probably be considerably diminished. A greater affected person overview can even present extra environment friendly administration and management – and create the muse for better equality in therapy.”
In keeping with one report from Menon Economics, reaching over 95 p.c eye screening protection for folks with diabetes may cut back Norway’s annual illness burden by roughly NOK 250 million.
“Diabetic retinopathy is the commonest complication of diabetes and the commonest reason for imaginative and prescient loss and blindness within the working age. The brand new AI answer will change the way in which we do retinal examinations,” mentioned ophthalmologist Maja Gran Erke, scientific undertaking supervisor within the regional undertaking Common Retinal Examination for Diabetic Retinopathy.
The EyeArt® AI Eye Screening System
The EyeArt AI system allows automated grading of retinal pictures in underneath 30 seconds, with out requiring an ophthalmologist’s evaluation. Outcomes will probably be saved immediately within the nationwide DIPS Enviornment digital medical file system, guaranteeing seamless integration into affected person care pathways.
EyeArt (model 3.0) is the primary and solely autonomous AI answer with Class IIb MDR CE marking for the automated detection of diabetic retinopathy (together with macular edema), age-related macular degeneration (AMD), and glaucomatous optic nerve harm—all from a single examination. EyeArt can be FDA-cleared within the U.S. for the detection of diabetic retinopathy, making it the one system with each CE Marking for 3 ailments and FDA clearance for diabetic retinopathy.
“This partnership marks a big milestone for Eyenuk,” mentioned Gaurav Agarwal, CEO of Eyenuk. “It’s our first deployment inside a nationwide well being system, and we’re proud that Norway has chosen the EyeArt system as its AI answer for diabetic eye screening. We stay up for serving to extra Norwegians defend their sight by guaranteeing they obtain well timed and efficient screenings.”
The settlement follows a aggressive procurement course of managed by Sykehusinnkjøp HF, the nationwide procurement group answerable for buying on behalf of Norway’s 4 regional well being authorities. The opposite three regional well being authorities—Helse Midt-Norge RHF, Helse Nord RHF, and Helse Vest RHF—additionally participated within the procurement and retain the choice to buy the EyeArt system for his or her areas.
Additionally Learn: Creating Autonomous Safety Brokers Utilizing Pc Imaginative and prescient and Generative AI
[To share your insights with us as part of editorial or sponsored content, please write to psen@itechseries.com]
